MARC details
000 -LEADER |
fixed length control field |
03622nam a22005417a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
181102s20192019 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
0003-4975 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1016/j.athoracsur.2018.08.068 [doi] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
S0003-4975(18)31478-4 [pii] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
30326232 |
245 ## - TITLE STATEMENT |
Title |
Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States. |
251 ## - Source |
Source |
Annals of Thoracic Surgery. 107(2):460-466, 2019 02. |
252 ## - Abbreviated Source |
Abbreviated source |
Ann Thorac Surg. 107(2):460-466, 2019 02. |
253 ## - Journal Name |
Journal name |
The Annals of thoracic surgery |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2019 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2019 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
aheadofprint |
266 ## - Date added to catalog |
Date added to catalog |
2018-11-02 |
501 ## - WITH NOTE |
Local holdings |
Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007 |
520 ## - SUMMARY, ETC. |
Abstract |
BACKGROUND: The primary surgical therapy for hypertrophic cardiomyopathy (HCM) with obstruction is septal myectomy (SM). The current outcomes of SM with and without concomitant mitral operations in the United States was examined using The Society of Thoracic Surgeons (STS) database. |
520 ## - SUMMARY, ETC. |
Abstract |
CONCLUSIONS: Septal myectomy for HCM is safe. SM alone may have risk-adjusted outcome advantages to SM+MVRR. SM and SM+MVr provide similar reduction in MR. Further longitudinal analyses are required to define technical efficacy and outcomes in selected pathoanatomic groups. |
520 ## - SUMMARY, ETC. |
Abstract |
Copyright (c) 2018. Published by Elsevier Inc. |
520 ## - SUMMARY, ETC. |
Abstract |
METHODS: From July 2014 through June 2017, 4,274 SM operations were performed. Emergent status, endocarditis, aortic stenosis, and planned aortic valve operations were excluded. In the final cohort of 2,382 patients, 1,581 (66.4%) received SM alone (Group 1), and 801 (33.6%) had SM with mitral valve repair or replacement (MVRR) (Group 2). Group 2 was subdivided into mitral valve repair (MVr, n=500) and replacement (MVR, n=301). Baseline characteristics were compared and risk-adjusted operative mortality and major morbidity were evaluated between treatment groups. |
520 ## - SUMMARY, ETC. |
Abstract |
RESULTS: Baseline comorbidity was lower in Group 1 vs. 2 and for MVr vs. MVR. Operative mortality and major morbidity was lower for Group 1 vs. 2 (1.6% vs. 2.8%, p=0.046; and 10.9% vs. 20.0%, p<0.001, respectively). For patients with severe 3-4+ mitral regurgitation (MR), SM alone was effective in reducing MR in 85.5% (355/415), and SM+MVr was effective in 88.0% (176/200), p=0.4061. Following risk adjustment, odds ratio for composite of mortality and major morbidity for Group 2 vs. Group 1 was 1.8 [95% CI 1.4-2.4] (p<0.0001). |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Cardiac Surgical Procedures/mt [Methods] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Cardiomyopathy, Hypertrophic/su [Surgery] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Heart Septum/su [Surgery] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Aged |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cardiomyopathy, Hypertrophic/ep [Epidemiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Female |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Follow-Up Studies |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Humans |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Male |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Middle Aged |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Prevalence |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Retrospective Studies |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Survival Rate/td [Trends] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Treatment Outcome |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
United States/ep [Epidemiology] |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Heart & Vascular Institute |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Thourani, Vinod H |
790 ## - Authors |
All authors |
Ad N, Ailawadi G, Alkhouli M, Badhwar V, Jacobs JP, McCarthy PM, Rankin JS, Roberts HG, Schaff HV, Smedira NG, Takayama H, Thibault DP, Thourani VH, Vemulapalli S, Wei LM, Yerokun B |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1016/j.athoracsur.2018.08.068">https://dx.doi.org/10.1016/j.athoracsur.2018.08.068</a> |
Public note |
https://dx.doi.org/10.1016/j.athoracsur.2018.08.068 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |